2022
DOI: 10.3389/fgene.2022.897083
|View full text |Cite
|
Sign up to set email alerts
|

Characterization of aging cancer-associated fibroblasts draws implications in prognosis and immunotherapy response in low-grade gliomas

Abstract: Background: Due to the highly variable prognosis of low-grade gliomas (LGGs), it is important to find robust biomarkers for predicting clinical outcomes. Aging cancer-associated fibroblasts (CAFs) within the senescent stroma of a tumor microenvironment (TME) have been recently reported to play a key role in tumor development. However, there are few studies focusing on this topic in gliomas.Methods and Results: Based on the transcriptome data from TCGA and CGGA databases, we identified aging CAF-related genes (… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(4 citation statements)
references
References 71 publications
0
4
0
Order By: Relevance
“…These alterations can change CAF phenotype, facilitate metastasis, and decrease response to therapy in cancer cells ( Turrell et al, 2023 ). Despite growing awareness of the dynamic evolution of CAFs ( Zhou et al, 2022 ), the secretory profile and modulatory role of CAFs in different stages of their life cycle are not fully characterized yet. Dissecting these changes in CAF phenotype is needed to guide CAF-targeting approaches effectively.…”
Section: Discussion and Perspectivesmentioning
confidence: 99%
“…These alterations can change CAF phenotype, facilitate metastasis, and decrease response to therapy in cancer cells ( Turrell et al, 2023 ). Despite growing awareness of the dynamic evolution of CAFs ( Zhou et al, 2022 ), the secretory profile and modulatory role of CAFs in different stages of their life cycle are not fully characterized yet. Dissecting these changes in CAF phenotype is needed to guide CAF-targeting approaches effectively.…”
Section: Discussion and Perspectivesmentioning
confidence: 99%
“…Two large statistical transcriptome and genomic analyses based on large databases of human gliomas revealed additional CAP markers whose expression correlates with patient prognosis. In particular, two clusters were observed in low-grade gliomas, with the first cluster representing cases with a poorer prognosis, a greater number of CAFs and marked expression of chitinase-3-like protein 1 (CHI3L1), a glycoprotein known to be associated with activation of antiapoptotic signaling pathways [114]. Statistical analysis of another database containing both low-grade and high-grade gliomas confirmed higher expression of a large number of CAF-associated cytokines in the high-grade group [115].…”
Section: Other Cellular Components Of the Tumor Environment In Gliomasmentioning
confidence: 99%
“…The rapid progress in highthroughput microarray technologies has enabled the identification of putative novel biomarkers, genetic variations, and biological pathways, thereby enhancing our comprehension of the pathogenesis and therapeutic intervention of various ailments (Li et al, 2021;. WGCNA (Langfelder and Horvath, 2008;Abu-Jamous and Clust, 2018;Zhou Z et al, 2022) and machine learning techniques are gradually improving, and these bioinformatics tools can be employed for providing great prospects for identifying the potential molecular mechanisms, biomarkers, and therapeutic targets for smoking-related OP and COPD, as well as other complex diseases. These technologies enable researchers to explore large datasets and identify key molecular pathways and biomarkers, leading to the discovery of new therapeutic interventions and improved patient outcomes (Kumar et al, 2021;.…”
Section: Introductionmentioning
confidence: 99%